{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T19:26:24Z","timestamp":1766777184538,"version":"3.48.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00dcB\u0130TAK","doi-asserted-by":"publisher","award":["123S357"],"award-info":[{"award-number":["123S357"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejps.2025.107372","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T15:54:55Z","timestamp":1762617295000},"page":"107372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparison of in vitro lipolysis, sequential lipolysis \u2013 ex vivo permeability, and simultaneous lipolysis - in situ perfusion for exemestane-loaded lipid-based formulations"],"prefix":"10.1016","volume":"216","author":[{"given":"Burcu","family":"Timur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seval","family":"Olgac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duygu","family":"Yilmaz Usta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murside Ayse","family":"Demirel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6359-5935","authenticated-orcid":false,"given":"Zeynep Safak","family":"Teksin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107372_bib0001","article-title":"Self-generating nano-emulsification techniques for alternatively-routed, bioavailability enhanced delivery, especially for anti-cancers, anti-diabetics, and miscellaneous drugs of natural, and synthetic origins","volume":"58","author":"Akhtar","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107372_bib0002","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s40610-015-0023-1","article-title":"Models for predicting drug absorption from oral lipid-based formulations","volume":"1","author":"Alsk\u00e4r","year":"2015","journal-title":"Curr. Mol. Biol. Rep."},{"key":"10.1016\/j.ejps.2025.107372_bib0003","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1208\/s12249-013-0065-8","article-title":"A prospective analysis of co-processed non-ionic surfactants in enhancing permeability of a model hydrophilic drug","volume":"15","author":"Alvi","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2025.107372_bib0004","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejpb.2018.07.003","article-title":"Introduction to the OrBiTo decision tree to select the most appropriate in vitro methodology for release testing of solid oral dosage forms during development","volume":"130","author":"Andreas","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0005","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3109\/03639045.2011.645834","article-title":"In vitro digestion kinetics of excipients for lipid-based drug delivery and introduction of a relative lipolysis half life","volume":"38","author":"Arnold","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0006","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2010.03.008","article-title":"SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization","volume":"391","author":"Basalious","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0007","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.addr.2019.06.010","article-title":"In vitro digestion models to evaluate lipid based drug delivery systems; present status and current trends","volume":"142","author":"Berthelsen","year":"2019","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107372_bib0008","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejpb.2017.05.001","article-title":"Simultaneous lipolysis\/permeation in vitro model, for the estimation of bioavailability of lipid based drug delivery systems","volume":"117","author":"Bibi","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0009","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.addr.2021.02.008","article-title":"Target specific tight junction modulators","volume":"171","author":"Brunner","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107372_bib0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejps.2011.12.007","article-title":"In vitro models to evaluate the permeability of poorly soluble drug entities: challenges and perspectives","volume":"45","author":"Buckley","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0011","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3390\/pharmaceutics12121194","article-title":"Self-nano-emulsifying drug-delivery systems: from the development to the current applications and challenges in oral drug delivery","volume":"12","author":"Buya","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107372_bib0012","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.biochi.2015.11.016","article-title":"Impact of gastrointestinal lipolysis on oral lipid-based formulations and bioavailability of lipophilic drugs","volume":"125","author":"Carri\u00e8re","year":"2016","journal-title":"Biochimie"},{"key":"10.1016\/j.ejps.2025.107372_bib0013","article-title":"A comprehensive review on novel delivery approaches for exemestane","volume":"75","author":"Chaturvedi","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107372_bib0014","article-title":"Development and optimization of nanoemulsion containing exemestane using box-behnken design","volume":"80","author":"Chaturvedi","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107372_bib0015","article-title":"Nano lipid based carriers for lymphatic voyage of anti-cancer drugs: an insight into the in-vitro, ex vivo, in-situ and in-vivo study models","volume":"59","author":"Chaturvedi","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107372_bib0016","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejps.2013.09.007","article-title":"Fed and fasted state gastro-intestinal in vitro lipolysis: in vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS","volume":"57","author":"Christophersen","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0018","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s11095-015-1843-7","article-title":"A new in vitro lipid digestion\u2013in vivo absorption model to evaluate the mechanisms of drug absorption from lipid-based formulations","volume":"33","author":"Crum","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107372_bib0017","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1021\/acs.molpharmaceut.6b00792","article-title":"Transient supersaturation supports drug absorption from lipid-based formulations for short periods of time, but ongoing solubilization is required for longer absorption periods","volume":"14","author":"Crum","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0019","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/jps.21246","article-title":"Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs","volume":"97","author":"Cuine","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0020","doi-asserted-by":"crossref","first-page":"21010","DOI":"10.3390\/molecules201219745","article-title":"Development and evaluation of liquid and solid self-emulsifying drug delivery systems for atorvastatin","volume":"20","author":"Czajkowska-Ko\u015bnik","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2025.107372_bib0021","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejpb.2007.01.017","article-title":"The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats","volume":"67","author":"Dahan","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0022","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1002\/jps.24258","article-title":"Direct in vivo human intestinal permeability (Peff) determined with different clinical perfusion and intubation methods","volume":"104","author":"Dahlgren","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0023","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF00542332","article-title":"Studies of the different metabolic pathways of antipyrine in man: oral versus iv administration and the influence of urinary collection time","volume":"21","author":"Danhof","year":"1982","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107372_bib0024","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2174\/1567201816666190820143957","article-title":"Formulation and in vitro evaluation of self microemulsifying drug delivery system containing atorvastatin calcium","volume":"16","author":"Diril","year":"2019","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107372_bib0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s40005-013-0069-0","article-title":"Enhanced solubility and permeability of exemestane solid dispersion powders for improved oral delivery","volume":"43","author":"Eedara","year":"2013","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.ejps.2025.107372_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106681","article-title":"Developing an in vitro lipolysis model for real-time analysis of drug concentrations during digestion of lipid-based formulations","volume":"194","author":"Ejskj\u00e6r","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0027","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1007\/s11095-013-1063-y","article-title":"Improved oral bioavailability of BCS class 2 compounds by self nano-emulsifying drug delivery systems (SNEDDS): the underlying mechanisms for amiodarone and talinolol","volume":"30","author":"Elgart","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107372_bib0028","unstructured":"EMA, Committee for Medicinal Products for Human Use (CHMP), 2010. Guideline On the Investigation of Bioequivalence. https:\/\/www.ema.europa.eu\/en\/investigation-bioequivalence-scientific-guideline (accessed 20 October 2025)."},{"key":"10.1016\/j.ejps.2025.107372_bib0029","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1023\/A:1016065715308","article-title":"Comparison between permeability coefficients in rat and human jejunum","volume":"13","author":"Fagerholm","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107372_bib0030","unstructured":"FDA, 1999. Aromasin\u00ae (exemestane) tablets. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/99\/20-753_Aromasin_prntlbl.pdf (accessed 27 March 2025)."},{"key":"10.1016\/j.ejps.2025.107372_bib0031","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbalip.2008.05.006","article-title":"Lipolysis of the semi-solid self-emulsifying excipient Gelucire\u00ae 44\/14 by digestive lipases","volume":"1781","author":"Fernandez","year":"2008","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids."},{"key":"10.1016\/j.ejps.2025.107372_bib0032","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1053\/gast.2000.18148","article-title":"Permeability of the rat small intestinal epithelium along the villus-crypt axis: effects of glucose transport","volume":"119","author":"Fihn","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejps.2025.107372_bib0033","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejps.2017.06.005","article-title":"Evaluation of the cytotoxicity and intestinal absorption of a self-emulsifying drug delivery system containing sodium taurocholate","volume":"106","author":"Gao","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0034","first-page":"50","article-title":"Development and validation of a RP-HPLC method for simultaneous determination of metformin hydrochloride, phenol red and metoprolol tartrate for intestinal perfusion studies. Lat","volume":"35","author":"Gulsun","year":"2016","journal-title":"Am. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0035","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.biopha.2004.02.001","article-title":"Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs","volume":"58","author":"Gursoy","year":"2004","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejps.2025.107372_bib0036","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.foodchem.2014.08.087","article-title":"Formation of vitamin D nanoemulsion-based delivery systems by spontaneous emulsification: factors affecting particle size and stability","volume":"171","author":"Guttoff","year":"2015","journal-title":"Food Chem."},{"key":"10.1016\/j.ejps.2025.107372_bib0037","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/acs.molpharmaceut.1c00861","article-title":"Exploring the predictive power of the in situ perfusion technique towards drug absorption: theory, practice, and applications","volume":"19","author":"Hens","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0038","article-title":"In vitro digestion-diffusion model for predicting in vivo performance of lipid-based formulations","volume":"83","author":"Higashino","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107372_bib0039","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1124\/dmd.112.044677","article-title":"Boosting of HIV protease inhibitors by ritonavir in the intestine: the relative role of cytochrome P450 and P-glycoprotein inhibition based on caco-2 monolayers versus in situ intestinal perfusion in mice","volume":"40","author":"Holmstock","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2025.107372_bib0040","first-page":"472","article-title":"Assessment of the potential drug-drug interaction between carvedilol and clopidogrel mediated through intestinal P-glycoprotein","volume":"71","author":"Incecayir","year":"2016","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejps.2025.107372_bib0042","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.xphs.2021.09.009","article-title":"Comparison of cellular monolayers and an artificial membrane as absorptive membranes in the in vitro lipolysis-permeation assay","volume":"111","author":"Keemink","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0043","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-5173(98)00054-4","article-title":"Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine","volume":"167","author":"Khoo","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0044","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/pharmaceutics13040489","article-title":"Estimating the oral absorption from self-nanoemulsifying drug delivery systems using an in vitro lipolysis-permeation method","volume":"13","author":"Klitgaard","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107372_bib0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejpb.2006.03.011","article-title":"Enhancing mechanism of Labrasol on intestinal membrane permeability of the hydrophilic drug gentamicin sulfate","volume":"64","author":"Koga","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0046","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0378-5173(00)00614-1","article-title":"Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment","volume":"212","author":"Kommuru","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0047","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ejps.2013.08.024","article-title":"In vitro models for the prediction of in vivo performance of oral dosage forms","volume":"57","author":"Kostewicz","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0048","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10146","article-title":"The assembly of integrated rat intestinal-hepatocyte cultures","volume":"5","author":"Kothari","year":"2020","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.ejps.2025.107372_bib0051","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/pharmaceutics12020134","article-title":"Absorption and intestinal metabolic profile of oleocanthal in rats","volume":"12","author":"L\u00f3pez-Yerena","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107372_bib0049","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijpharm.2011.03.002","article-title":"In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems","volume":"417","author":"Larsen","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106255","article-title":"Comparision of the phenol red, gravimetric, and synthesized mPEG-PR methods for correcting water flux using the single-pass intestinal perfusion method","volume":"176","author":"Liu","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125007","article-title":"Enhancing oral bioavailability of dasatinib via supersaturable SNEDDS: investigation of precipitation inhibition and IVIVC through in-vitro lipolysis-permeation model","volume":"668","author":"Mageshvaran","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0053","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijpharm.2007.11.051","article-title":"Hydrogel-thickened nanoemulsion system for topical delivery of lipophilic drugs","volume":"353","author":"Mou","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0041","unstructured":"IOI Oleo GmbH, 2025. https:\/\/www.ioioleo.de\/en\/products\/pharma\/imwitor-988\/ (accessed 27 March 2025)."},{"key":"10.1016\/j.ejps.2025.107372_bib0054","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4103\/0250-474X.108441","article-title":"Intestinal permeability of lamivudine using single pass intestinal perfusion","volume":"74","author":"Patel","year":"2012","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0057","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.addr.2007.10.010","article-title":"Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies","volume":"60","author":"Pouton","year":"2008","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107372_bib0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0169-409X(96)00490-5","article-title":"Formulation of self-emulsifying drug delivery systems","volume":"25","author":"Pouton","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107372_bib0056","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejps.2006.04.016","article-title":"Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system","volume":"29","author":"Pouton","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0058","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jddst.2017.02.002","article-title":"Formulation and evaluation of self-emulsifying drug delivery system for nimodipine, a BCS class II drug","volume":"39","author":"Prajapat","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107372_bib0059","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0378-5173(99)00056-3","article-title":"Design and characterization of a surfactant-enriched tablet formulation for oral delivery of a poorly water-soluble immunosuppressive agent","volume":"182","author":"Ruddy","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jcis.2012.08.069","article-title":"Fabrication of vitamin E-enriched nanoemulsions: factors affecting particle size using spontaneous emulsification","volume":"391","author":"Saberi","year":"2013","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0061","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1208\/s12248-014-9672-x","article-title":"Toward the establishment of standardized in vitro tests for lipid-based formulations, part 6: effects of varying pancreatin and calcium levels","volume":"16","author":"Sassene","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2025.107372_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106732","article-title":"Development and characterization of solid lipid-based formulations (sLBFs) of ritonavir utilizing a lipolysis and permeation assay","volume":"196","author":"Schulzen","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2023.103028","article-title":"Critical aspects involved in lipid dispersion and digestion: emphasis on in vitro models and factors influencing lipolysis of oral lipid based formulations","volume":"321","author":"Sirvi","year":"2023","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0065","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1021\/acs.molpharmaceut.8b00206","article-title":"Polymeric precipitation inhibitors promote fenofibrate supersaturation and enhance drug absorption from a type IV lipid-based formulation","volume":"15","author":"Suys","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0064","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2021.01.007","article-title":"Interaction with biliary and pancreatic fluids drives supersaturation and drug absorption from lipid-based formulations of low (saquinavir) and high (fenofibrate) permeability poorly soluble drugs","volume":"331","author":"Suys","year":"2021","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejps.2025.107372_bib0067","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1021\/acs.molpharmaceut.1c00015","article-title":"Digestion of lipid-based formulations not only mediates changes to absorption of poorly soluble drugs due to differences in solubilization but also reflects changes to thermodynamic activity and permeability","volume":"18","author":"Tanaka","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0066","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1021\/acs.molpharmaceut.4c00161","article-title":"In vitro digestion\u2013In situ absorption setup employing a physiologically relevant value of the membrane surface area\/volume ratio for evaluating performance of lipid-based formulations: a comparative study with an In vitro digestion\u2013Permeation model","volume":"21","author":"Tanaka","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0068","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/jps.23054","article-title":"Influence of lipid composition and drug load on the in vitro performance of self-nanoemulsifying drug delivery systems","volume":"101","author":"Thomas","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0069","article-title":"Investigation of the effect of colloidal structures formed during lipolysis of lipid-based formulation on exemestane permeability using the in vitro lipolysis-permeation model","volume":"77","author":"Timur","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107372_bib0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejps.2014.05.016","article-title":"Validation of phenol red versus gravimetric method for water reabsorption correction and study of gender differences in Doluisio\u2019s absorption technique","volume":"62","author":"Tu\u011fcu-Demir\u00f6z","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0071","first-page":"1","article-title":"Development and optimization of hydrogel-forming microneedles fabricated with 3d-printed molds for enhanced dermal diclofenac sodium delivery: a comprehensive in vitro, ex vivo, and in vivo study","author":"Tun\u00e7el","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2025.107372_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106159","volume":"174","author":"Usta","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0072","article-title":"Development and pharmacokinetic evaluation of Neusilin\u00ae US2-based S-SNEDDS tablets for bosentan: fasted and fed states bioavailability, IVIS\u00ae real-time biodistribution, and ex vivo imaging","volume":"643","author":"Usta","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0074","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jcis.2008.10.077","article-title":"Design and optimization of a new self-nanoemulsifying drug delivery system","volume":"330","author":"Wang","year":"2009","journal-title":"J. Colloid Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0075","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.3892\/mmr.2014.2126","article-title":"Effects of alcohol on intestinal epithelial barrier permeability and expression of tight junction\u2011associated proteins","volume":"9","author":"Wang","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejps.2025.107372_bib0076","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1002\/jps.23205","article-title":"Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations","volume":"101","author":"Williams","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0077","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1208\/s12249-009-9190-9","article-title":"Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid","volume":"10","author":"Xi","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2025.107372_bib0078","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2010.07.046","article-title":"Alternative oral exemestane formulation: improved dissolution and permeation","volume":"398","author":"Yavuz","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107372_bib0079","first-page":"3865","article-title":"Development and optimization of a self-microemulsifying drug delivery system for ator vastatin calcium by using d-optimal mixture design","author":"Yeom","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2025.107372_bib0080","first-page":"368","article-title":"Predicting human intestinal permeability using single-pass intestinal perfusion in rat","volume":"10","author":"Zakeri-Milani","year":"2007","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107372_bib0081","doi-asserted-by":"crossref","first-page":"19815","DOI":"10.1039\/C6RA27096D","article-title":"Development and characterization of promising Cremophor EL-stabilized o\/w nanoemulsions containing short-chain alcohols as a cosurfactant","volume":"7","author":"Zeng","year":"2017","journal-title":"RSC Adv"},{"key":"10.1016\/j.ejps.2025.107372_bib0082","article-title":"Preparation and in vitro characterization of a novel self-nano emulsifying drug delivery system for a fixed-dose combination of candesartan cilexetil and hydrochlorothiazide","volume":"61","author":"Zewail","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107372_bib0083","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: an add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2025.107372_bib0084","series-title":"Developing Solid Oral Dosage forms: Pharmaceutical Theory and Practice","first-page":"297","article-title":"Oral absorption basics: pathways and physicochemical and biological factors affecting absorption","author":"Zhu","year":"2017"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725003690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725003690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T19:23:38Z","timestamp":1766777018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725003690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":84,"alternative-id":["S0928098725003690"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107372","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of in vitro lipolysis, sequential lipolysis \u2013 ex vivo permeability, and simultaneous lipolysis - in situ perfusion for exemestane-loaded lipid-based formulations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107372"}}